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Edited by Maurice MontalAbstract In the central nervous system, synaptic signal trans-
duction depends on the regulation of neurotransmitter receptors
by interacting proteins. Here, we searched for proteins interact-
ing with two metabotropic glutamate receptor type 8 isoforms
(mGlu8a and mGlu8b) and identiﬁed RanBPM. RanBPM is ex-
pressed in several brain regions, including the retina. There, Ran-
BPM is restricted to the inner plexiform layer where it co-
localizes with the mGlu8b isoform and processes of cholinergic
amacrine cells expressing mGlu2 receptors. RanBPM interacts
with mGlu2 and other group II and group III receptors, except
mGlu6. Our data suggest that RanBPM might be associated
with mGlu receptors at synaptic sites.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Glutamate is the major excitatory neurotransmitter in the
central nervous system (CNS), acting on ion channel-associ-
ated (ionotropic) and G-protein-coupled (metabotropic) gluta-
mate receptors. Metabotropic glutamate receptors (mGlu
receptors) regulate various intracellular second messenger sys-
tems that modulate neuronal excitability and development,
synaptic plasticity, transmitter release, memory function and
neurodegeneration [1]. Eight diﬀerent mGlu receptors have
been cloned that are subdivided into three groups. Receptors
of group I (mGlu1 and mGlu5) activate phospholipase C,
while group II (mGlu2 and mGlu3) and group III (mGlu4
and mGlu6–8) receptors preferentially reduce adenylyl cyclase
activity [2]. Besides coupling to various signal cascades, mGlu
types also diﬀer in their sub-cellular localization. For example,Abbreviations: ChAT, choline acetyltransferase; CNS, central nervous
system; EF1a, elongation factor 1a; FLNA, Filamin-A; b-Gal, b-
galactosidase; GCL, ganglion cell layer; GST, glutathione-S-transfer-
ase; HIPK2, Homeodomain-interacting protein kinase 2; INL, inner
nuclear layer; IPL, inner plexiform layer; mGlu receptor, metabotropic
glutamate receptor; MOR, mu-opioid receptor; ONL, outer nuclear
layer; OPL, outer plexiform layer; Pc2, polycomb protein 2; PIAS,
protein inhibitor of activated STAT; RanBPM, Ran binding protein in
the microtubule-organizing center; ROK, Rho-associated kinase; Ubc,
ubiquitin conjugating enzyme
*Corresponding author. Fax: +49 9131 852 2485.
E-mail address: ralf.enz@biochem.uni-erlangen.de (R. Enz).
0014-5793/$34.00  2008 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2008.06.010mGlu1 receptors are expressed at postsynaptic sites, whereas
mGlu8 receptors are found presynaptically and thus suggested
to function as autoreceptors [3].
The correct regulation of mGlu receptors represents an
important biological mechanism to control neuronal excitabil-
ity. Neurotransmitter receptors, enzymes and scaﬀold proteins
assemble into macromolecular signal complexes that ensure
the correct function of synaptic signal transduction, both in
space and time. Therefore, mGlu binding partners are impor-
tant regulators of glutamatergic neurotransmission in the
CNS. Indeed, several mGlu interacting proteins were identiﬁed
in recent years [4].
Here, we performed yeast two-hybrid screens against the intra-
cellular C-termini of twomGlu8 isoforms (mGlu8a andmGlu8b)
and identiﬁedRan binding protein in themicrotubule-organizing
center (RanBPM) as a new binding partner. RanBPM has been
described as a scaﬀold for signal proteins, involved in the regula-
tion of the immune and the nervous system [5].2. Materials and methods
2.1. Yeast two-hybrid techniques
MGlu8a or mGlu8b C-termini (rat) were used as baits to screen a rat
brain cDNA-library for interacting proteins using the MATCH-
MAKER GAL4 Two-Hybrid System 3 (Clontech, Mountain View,
CA) as described [6]. Colonies were grown for 5 days at 30 C on selec-
tion plates containing 10 mM 3-amino-1,2,4-triazole (Sigma–Aldrich,
Munich, Germany). Isolation and sequencing of library plasmid was
described previously [7]. Semi-quantitative binding intensities were cal-
culated from 3 to 4 yeast colonies according to the ‘‘Yeast Protocols
Handbook’’ from Clontech and visualized as arbitrary b-galactosidase
(b-Gal) units. The background signal intensity of non-interacting pro-
teins (0.0675 ± 0.048 b-Gal units) was subtracted from all values. The
positive control (pGBKT7-53 + pGADT7-T) was 1.566 ± 0.047 b-Gal
units. Error bars are ±S.E.M.
2.2. Glutathione-S-transferase (GST) pull-down assays
The coding sequence of RanBPM (human) was cloned into pET21
(Novagen, Madison, WI) for in vitro expression in the presence of
[35S]methionine (MP Biomedicals, Eschwege, Germany) using the
TnT Quick Coupled Transcription/Translation System (Promega,
Mannheim, Germany). Alternatively, HEK-293 cells were transfected
with an eukaryotic expression plasmid encoding for the human form
of RanBPM containing a C-terminal FLAG-epitope [8], cultivated
and lysed as described previously [7]. The rat mGlu2 C-terminus was
ligated to the coding sequence of GST in pET-41 (Novagen), expressed
in Escherichia coli (E. coli) puriﬁed and immobilized under native con-
ditions on glutathione Sepharose using the BugBuster GST-Bind-Puri-
ﬁcation Kit (Novagen). Coated glutathione Sepharose was incubated
with in vitro translated RanBPM in the presence of 0.1% Triton X-
100 and 0.1% bovine serum albumin, or with the RanBPM containing
fraction of lysed HEK-293 cells, and washed as described [6]. Protein
gels were dried and analyzed with ﬂuoroimager STORM 860 (GEblished by Elsevier B.V. All rights reserved.
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tag speciﬁc antibodies (1:2500, Sigma–Aldrich) and the enhanced che-
moluminescence system (GE Healthcare). Individual domains of Ran-
BPM were generated by PCR cloning techniques, tagged with a N-
terminal T7-epitope by ligation in pET-21 (Novagen) and expressed
in E. coli. Binding assays and detection of T7-tagged proteins by wes-
tern blotting was described previously [7].
2.3. RT-PCR
Total RNA was extracted from adult rat tissues, reverse transcribed
and ampliﬁed as described [6] using primer pairs speciﬁc for RanBPM
(sense nt1206–1230; antisense nt1841–1823). Primers for the house
keeping gene elongation factor 1a (EF1a) (sense nt1479–1497; anti-
sense nt1770–1749) served as positive control. Both PCR products
were identiﬁed by DNA sequencing.
2.4. Immunocytochemistry
Retinal cryostat sections of adult mice were prepared as described [6]
and incubated with primary antibodies recognizing murine RanBPM
(1:500 [8]), mGlu2/3 receptors (1:200; Chemicon, Temecula, CA) spe-
ciﬁcally labeling mGlu2 in the retina [9], mGlu8a (1:5000; Chemicon)
or mGlu8b receptors (1:1000 [10]), or choline acetyltransferase (ChAT)
(1:200; Chemicon). In addition, retina sections were co-stained with
4,6-diamidino-2-phenylindole (DAPI; 1:5000, Sigma–Aldrich). The
binding sites of the primary antibodies were revealed by the secondary
antibodies Alexa 594 and Alexa 488 coupled to red or green ﬂuo-
rescence (1:500; Molecular Probes, Eugene, OR, USA). In control
experiments, the secondary antibodies were omitted, resulting in a
complete loss of speciﬁc immunoreactivity. Labeled proteins were
examined by conventional or confocal microscopy (DMIRB or TCS
SL, Leica, Microsystems, Wetzlar, Germany).Fig. 1. RanBPM binds to mGlu C-termini and is expressed in the
mammalian retina. (A) Membrane topology of mGlu receptors. A gray
box represents the membrane and transmembrane regions 1–7 are
indicated by black rectangles. The intracellular C-terminus (bold) is
alternatively spliced (triangle). (B) Proteins identiﬁed in yeast two-
hybrid screens against mGlu8a and mGlu8b C-termini. (C) Agarose
gels showing PCR products ampliﬁed from reverse transcribed mRNA
isolated from diﬀerent CNS regions. (D) Retinal cryostat section
incubated with RanBPM speciﬁc antibodies (red, left panel). Retinal
layers are indicated by co-staining the same section with DAPI (blue,
right panel). Arrows point to two horizontal strata in the IPL labeled
for RanBPM and arrowheads indicate stained blood vessels. Scale bar:
40 lm.3. Results
3.1. RanBPM is a new mGlu binding partner and is expressed in
synaptic layers of the retina
Yeast two-hybrid screens with the intracellular C-termini of
mGlu8a or mGlu8b receptors (Fig. 1A) yielded 12 · 106 trans-
formants each. Further analyzes of 200 candidates identiﬁed
several potential mGlu8 interactors, including the already
known mGlu8 binding proteins Filamin-A (FLNA), protein
inhibitor of activated STAT 1 (PIAS1) and ubiquitin conjugat-
ing enzyme 9 (Ubc9) [11,12] (Fig. 1B). Here, we focus on Ran-
BPM that was identiﬁed in ﬁve clones representing two diﬀerent
open reading frames (amino acids 104–729 and 112–729).
Co-expression of binding partners is a pre-requisite for pro-
tein–protein interactions. RanBPM may function as a scaﬀold
between membrane receptors and intracellular signal pathways
in the nervous system [5], and its expression in several CNS re-
gions has been described [13,14]. The retina is widely used as a
model for the CNS because of its clear organization in diﬀerent
horizontal layers. Therefore, we ﬁrst ensured that RanBPM is
expressed in the retina in comparable amounts to other CNS
regions (Fig. 1C). Next, we analyzed the distribution of Ran-
BPM in vertical cryostat sections of the mouse retina. Ran-
BPM speciﬁc antibodies labeled two horizontal strata in the
inner synaptic layer (inner plexiform layer (IPL), arrows in
Fig. 1D). In contrast, retinal cell bodies visualized by staining
their nuclei with DAPI do not express RanBPM.
3.2. RanBPM co-localizes with processes of cholinergic
amacrine cells, mGlu2 and mGlu8b receptors
To compare the localization of RanBPM with those of
mGlu8a and mGlu8b receptors, we used mGlu8 isoform spe-
ciﬁc antibodies (Fig. 2). The retinal expression of mGlu8a,
but not of mGlu8b receptors was analyzed in detail before[3,15]. Similar to RanBPM, strong mGlu8a signals were de-
tected in the IPL. However, the two proteins show no signiﬁ-
cant co-localization (Fig. 2, upper half). MGlu8b speciﬁc
label was present in synaptic layers (IPL) and in cell bodies
of nuclear layers (inner nuclear layer (INL), ganglion cell layer
(GCL) and faintly in the outer nuclear layer (ONL)). Within
the IPL, high expression of mGlu8b receptors was visible in
Fig. 2. RanBPM co-localizes with mGlu8b receptors. Retinal cryostat
sections double-immunolabeled for RanBPM and mGlu8a or mGlu8b
isoforms, as indicated. The larger panels (merge) show magniﬁed views
of the IPL to compare the localization of red and green signals. Arrows
point to horizontal strata labeled for RanBPM or mGlu8b receptors.
Arrowheads indicate stained blood vessels. Scale bar: 40 lm.
Fig. 3. RanBPM co-localizes with mGlu2 receptors in processes of
cholinergic amacrine cells. Confocal micrographs of retinal cryostat
sections double-immunolabeled for RanBPM and ChAT as a marker
for cholinergic amacrine cells, mGlu2 receptors and ChAT or
RanBPM, as indicated. Asterisk label somata of cholinergic amacrine
cells in the INL and GCL. Arrows point to horizontal strata labeled
for RanBPM, ChAT or mGlu2 receptors. Arrowheads indicate stained
blood vessels. Scale bar: 40 lm.
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localizes with RanBPM immunoreactivity.
Horizontal strata within the IPL are formed by speciﬁc syn-
aptic contacts between retinal neurons. The two horizontal
RanBPM positive strata are indicative of processes of cholin-
ergic amacrine cells [16]. Therefore, we co-stained retinal cryo-
stat sections for RanBPM and a marker for cholinergic
amacrine cells (ChAT) and detected extensive co-localization
of both signals in the IPL (Fig. 3, upper panels).
Because mGlu2 receptors are expressed in processes of cho-
linergic amacrine cells [9], we compared the expression pattern
of RanBPM with this glutamate receptor. MGlu2 receptors are
present in three horizontal strata within the IPL (Fig. 3, middle
panels). Of these, the upper two co-localize with ChAT posi-
tive amacrine cell processes, as well as with RanBPM speciﬁc
signals (Fig. 3, lower panels).
3.3. RanBPM binds to group II and group III mGlu types
The precise co-localization between RanBPM and mGlu2
receptors encouraged us to test if RanBPM would bind toadditional mGlu types besides the mGlu8 isoforms. Protein
interactions were monitored in vivo by the ability of trans-
formed yeast cells to activate their reporter genes. Except for
Fig. 4. RanBPM binding characteristics. (A) Relative aﬃnities of
RanBPM for group II and group III mGlu C-termini were quantiﬁed
in yeast and visualized as arbitrary b-Gal units (horizontal columns).
(B) GST or GST fused to the mGlu2 C-terminus was immobilized on
glutathione Sepharose and incubated with RanBPM translated in vitro
or recombinantly expressed in HEK-293 cells. Protein concentrations
of coated beads are shown on Coomassie stained SDS–PAGE
(arrowheads in the lower panel). (C) Domain structure of RanBPM
(SPRY – dual-speciﬁc kinase splA and ryanodine receptor; L (LisH) –
lissencephaly type-1-like homology; CTLH – C-terminal to LisH; CRA
– CT11-RanBPM). Glutathione Sepharose from (B) was incubated
with E. coli protein extracts containing RanBPM fragments, and
bound proteins were detected by Western blotting.
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mGlu2 receptors (Fig. 4A).
Because mGlu2 receptors showed (i) a perfect co-localiza-
tion and (ii) a good binding capability for RanBPM (Figs. 3
and 4A), we concentrated our further studies on this glutamate
receptor. GST pull-down assays using RanBPM translated
in vitro or expressed in HEK-293 cells veriﬁed the protein
interaction detected in yeast (Fig. 4B). This protein interaction
is mediated by the CTLH domain and a C-terminally adjacent
protein region of RanBPM, while other domains showed no
binding aﬃnity for mGlu2 receptors (Fig. 4C).4. Discussion
Scaﬀold proteins are central components of macromolecular
signal complexes that regulate neuronal excitability by assem-bling neurotransmitters receptors, enzymes and other proteins
[4]. Our yeast two-hybrid screens identiﬁed several new protein
interactions with mGlu8a/b receptors including RanBPM, as
well as previously known mGlu8 interactors. The FLNA re-
peats 21 and 22 bind mGlu8a, but not mGlu8b isoforms
[11]. Consistently, we identiﬁed diﬀerent open reading frames
covering FLNA repeats 21 and 22 in the screen against
mGlu8a, but not against mGlu8b receptors. On the other
hand, we found PIAS1 and Ubc9 exclusively in the screen
against mGlu8b receptors, although these proteins were re-
ported to bind both mGlu8 isoforms [12].
Here, we describe RanBPM as a new interactor of mGlu
receptors that is abundantly expressed in brain and retina.
Although its name places RanBPM in the Ran binding protein
family, RanBPM lacks a consensus Ran-binding domain.
Thus, diverse functions of RanBPM have been suggested,
including its involvement in signal transduction from cell sur-
face receptors to intracellular signal pathways [5]. Besides
binding to diﬀerent mGlu types, preliminary evidence indicates
that RanBPM interacts with other G-protein-coupled recep-
tors, such as the mu-opioid receptor (MOR) [5]. Recently,
functional connections between MOR and mGlu types were
described. First, MOR and mGlu8 receptors might be both in-
volved in heroin addiction [17]. Furthermore, mGlu2 receptors
enhance the eﬃcacy of MOR, thereby increasing morphine-in-
duced antinociception in mice [18]. Finally, knockout mice for
the mGlu2 interactor tamalin are less sensitive for morphine
[19].
The CRA domain of RanBPM contains the sequence (RMI-
HF) representing a docking motif for protein phosphatase 1
[20]. Because we identiﬁed more N-terminal located regions
of RanBPM to be responsible for mGlu2 binding, RanBPM
could serve as a linker between mGlu2 receptors and protein
phosphatase 1. Furthermore, the SPRY domain would be
accessible for additional protein interactions, inserting mGlu2
receptors into large protein complexes. The same might hold
true for other mGlu types interacting with RanBPM. Indeed,
RanBPM was found in a protein complex of more than
670 kDa [21].
Overexpressed RanBPM was found in the nucleus and the
cytoplasm [22,23]. In contrast, endogenous RanBPM of cell
lines and epithelial cells of lung, kidney and breast was unde-
tectable in the nucleus, but localized in the cytoplasm and the
plasma membrane [8]. In the CNS, endogenous RanBPM was
found in nuclei and cytoplasm of neurons in the cerebral cor-
tex and the cerebellum [13]. This heterogeneity might be ex-
plained by recent data suggesting that the localization of
RanBPM depends on interacting proteins [23]. In the retina,
we detected RanBPM exclusively outside the nucleus, concen-
trated in processes of cholinergic amacrine cells. Because there
the protein co-localizes with mGlu2 and mGlu8b receptors,
and because mGlu2 receptors are expressed at synapses of cho-
linergic amacrine cells [9], we suggest that RanBPM might be
associated with these glutamate receptors at synaptic sites.
Clearly, more detailed biochemical and anatomical studies
e.g. on the electron-microscopic level are needed to resolve this
issue.
Cholinergic amacrine cells express mGlu2 receptors and are
responsible for generating directional selectivity in ganglion
cells. Consistently, activation of group II receptors in choliner-
gic amacrine cells inhibits acetylcholine release and reduces
directional selectivity in ganglion cells [24]. In heterologous
A. Seebahn et al. / FEBS Letters 582 (2008) 2453–2457 2457expression systems, mGlu2 and mGlu8 receptors are nega-
tively coupled to adenylyl cyclase. However, in the retina sig-
nal cascades associated with these two glutamate receptors
were investigated for mGlu8 in photoreceptors only [25]. Be-
cause RanBPM deﬁcient mice are not described, and mGlu2
or mGlu8 knockout animals show no retinal phenotype [26–
28], possible functions of the reported protein interactions
are only speculative at the moment.
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